Drug Profile
PNU 80873A
Latest Information Update: 11 Jun 2001
Price :
$50
*
At a glance
- Originator Pharmacia Corporation
- Class Antihypertensives
- Mechanism of Action Diuretics
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 11 Jun 2001 No-Development-Reported for Hypertension in USA (Unknown route)
- 19 Sep 1997 New profile
- 19 Sep 1997 Preclinical development for Hypertension in USA (Unknown route)